← Back to Search

Conventional intensive functional rehabilitation + Workstations for Stroke

N/A

Recruiting

Led By Cyril Duclos, PhD

Research Sponsored by Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up end-measure, at the end of rehabilitation

Awards & highlights

Study Summary

This trial aims to see if workstations for mobility training can help increase the level of motor activity for people with hemiparesis (weakness on one side of the body) due to a stroke.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ end-measure, at the end of rehabilitation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~end-measure, at the end of rehabilitation

This trial's timeline: 3 weeks for screening, Varies for treatment, and end-measure, at the end of rehabilitation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Actimetry

Secondary outcome measures

Balance capacities

Gait speed

Gross manual dexterity

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intensive rehabilitation with workstationsExperimental Treatment1 Intervention

Group II: Intensive rehabilitation without workstationActive Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Centre for Interdisciplinary Research in Rehabilitation of Greater MontrealLead Sponsor

14 Previous Clinical Trials

2,062 Total Patients Enrolled

1 Trials studying Stroke

24 Patients Enrolled for Stroke

Cyril Duclos, PhDPrincipal InvestigatorCIUSSS Centre-Sud-de-l'ile-de-Montréal

1 Previous Clinical Trials

21 Total Patients Enrolled

Media Library

Conventional intensive functional rehabilitation Clinical Trial Eligibility Overview. Trial Name: NCT04787315 — N/A

Stroke Research Study Groups: Intensive rehabilitation without workstation, Intensive rehabilitation with workstations

Stroke Clinical Trial 2023: Conventional intensive functional rehabilitation Highlights & Side Effects. Trial Name: NCT04787315 — N/A

Conventional intensive functional rehabilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04787315 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what demographic is this clinical research accessible?

"To be eligible to take part in this research, individuals must have had a stroke and should between 18 years old and 100. The trial is looking for approximately 60 participants."

Answered by AI

Are applicants younger than 60 years old allowed to participate in this experiment?

"The eligibility requirements for this medical trial clearly state that participants need to be aged 18 or higher, and must not exceed 100 years old."

Answered by AI

What is the sample size for this experimental treatment?

"Indeed, the information hosted on clinicaltrials.gov confirms that this research is actively searching for candidates to join their trial. This was initially posted on October 5th 2019 and edited lastly on June 7th 2022. Approximately 60 participants need to be acquired from a single medical facility."

Answered by AI

Are researchers presently enrolling participants for this experiment?

"The information on clinicaltrials.gov verifies that this experiment is currently in search of participants. The study's initial posting date was October 5th 2019 and has been updated as recently as June 7th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Reaching Clinical Recommendations for Intensity of Post-stroke Rehabilitation

Cyril Duclos 2019. "Reaching Clinical Recommendations for Intensity of Post-stroke Rehabilitation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04787315.